MedPath

CRYSVITA

CRYSVITA

Approved
DIN Number

02483645

Drug Class

Human

Market Date

Jan 28, 2019

Company
HC

Kyowa Kirin, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02483645
AIG Number0160950003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
M05BX05 BUROSUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification40:92.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

BUROSUMABActive
Strength: 30 MG / ML
Monograph: BUROSUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.